Form 4 AEMETIS, INC For: Apr 19 Filed by: FOSTER ANDREW B

April 21, 2021 6:20 PM EDT

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0287
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person ^*

FOSTER ANDREW B

(Last)

(First)

(Middle)

20400 STEVENS CREK BLVD, SUITE 700

(Street)

CUPERTINO

95014

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AEMETIS, INC [ AMTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
04/19/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Option (right to buy)	$ 2.54	04/19/2021		D			68,000	08/19/2016⁽¹⁾	05/21/2026	Common stock and Series B Preferred	78,500	$ 18.6479	32,000	D
Option (right to buy)	$ 1.72	04/19/2021		D			90,942	04/19/2017	01/19/2027	Common stock and Series B Preferred	100,000	$ 18.6479 ⁽²⁾ ⁽³⁾	9,058	D
Option (right to buy)	$ 0.92	04/19/2021		D			33,304	09/06/2019	06/05/2029	Common stock and Series B Preferred	35,000	$ 18.6479 ⁽⁴⁾	26,696	D
Option (right to buy)	$ 0.86	04/19/2021		D			39,779	04/09/2020	01/09/2030	Common stock and Series B Preferred	41,666	$ 18.6479 ⁽⁵⁾	60,221	D
Option (right to buy)	$ 2.59	04/19/2021		D			4,138	03/10/2016	12/10/2025	Common stock and Series B Preferred	20,000	$ 18.6479 ⁽⁶⁾	13,134	D
Option (right to buy)	$ 2.59	04/20/2021		D			10,000	03/10/2016	12/10/2025	Common stock and Series B Preferred	13,134	$ 17.7075 ⁽⁶⁾	3,134	D

Explanation of Responses:

1. 1/12th of the Option Shares vest every three(3)months from the date of the grant.

2. The 1-19-2017 option grant was exercised and sold through 10b5-1 plan.

3. The 1-19-2017 option grant was exercised and sold through 10b5-1 plan sold as below

4. The 6-06-2019 option grant was exercised and sold through 10b5-1 plan.

5. The 1-9-2020 option grant was exercised and sold through 10b5-1 plan.

6. The shares were exercised from warrant grant 12/10/2015 and sold through executing the 10b5-1 plan.

	/s/Todd Waltz attorney-infact	04/21/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP

6. SPY
7. BSX
8. NOW
9. PI
10. ORCL

Create E-mail Alert Related Categories

SEC Filings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Form 4 AEMETIS, INC For: Apr 19 Filed by: FOSTER ANDREW B

You May Also Be Interested In

Create E-mail Alert Related Categories

Sign up for StreetInsider Free!

Free News Feed